• 제목/요약/키워드: microshpere

검색결과 2건 처리시간 0.017초

3차원 구조의 $LiMn_2O_4$ 박막전극의 제조 및 전기화학적 특성 (Fabricatoin and electrochemical property of 3-dimesional $LiMn_2O_4$ thin film)

  • 박보건;유제혁;박용준
    • 한국전기전자재료학회:학술대회논문집
    • /
    • 한국전기전자재료학회 2008년도 하계학술대회 논문집 Vol.9
    • /
    • pp.64-65
    • /
    • 2008
  • 3D microbattery에 사용할 수 있는 $LiMn_2O_4$ 3차원 박막전극을 제조하여 그 전기화학적 특성을 관찰하였다. 3차원 구조의 형성을 위하여 먼저 polystyrene(PS) microsphere를 platinum이 증착된 Si/$SiO_2$ 기판위에 dip-coating 방식으로 코팅시켜 template로 사용하였다. 그 위에 sol-gel법을 이용, 박막을 형성시킨 후 template 를 제거하는 방식으로 $LiMn_2O_4$ 3차원 박막전극을 형성하였는데 이때 solution은 Lithium acetylacetonate[$LiCH_3CO-CHCOCH_3$], Manganese(III) acetylacetonate [Mn$(CH_3COCHCOCH_3)_3$]를 source 물질로 1-butanol과 acetic acid를 solvent로 활용하여 제조하였다.

  • PDF

Biodistribution of [S-35] Labeled Antisense Oligodeoxynucleotides Increased Tumor Targeting With Microsphere Coinjection

  • Choe, Jae-Gol;Park, Gil-Hong;Claudio Nastruzzi;Yoon S. Cho-Chung;Kim, Meyoung-Kon
    • 한국환경성돌연변이발암원학회지
    • /
    • 제22권2호
    • /
    • pp.65-69
    • /
    • 2002
  • To elucidate the effect of microsphere coinjection on the administration of oligodeoxynucleotides (ODN), we have investigated biodistribution of [S-35]-labeled antisense ODN targeted to cAMP-dependent protein kinase (PKA) RI-$\alpha$ subunit in nude mice xenografted with WiDr (human colon cancer, ATCC CCL218). The strategy of using microsphere has been proposed for cancer treatment as a carrier of therapeutic ODN so that it could offer an advantage with respect to maintaining constant ODN levels in blood and obtaining higher therapeutic ODN concentration at tumor sites. Comparative biodistribution studies were performed in nude mice (female, 20 g of body weight, n = 4-6) xenografted with WiDr cancer cells, when 0.1 $\mu$Ci (specific activity, 2.94 mCi/$\mu$mole) of [S-35]-labeled RI-$\alpha$ antisense ODN was injected alone or with microsphere (PLG-18, polylactic copolymer with cationic surfactant DDAB18). Peak tumor uptake of [S-35]-labeled ODN was significantly increased from 17.7% (at 6 h) of injected dose per gram of tissue (ID/g) to 42.5% (at 24 h) ID/g when microsphere was coinjected with ODN. The different biodistribution in the kidney accumulation (e.g., 100.2% ID/g for ODN alone and 54.9%/ID/g for microshpere coinjection) may contribute to higher blood concentration (e.g., 21.5%ID/$m\ell$ for ODN alone and 37.5%ID/$m\ell$ for microsphere coinjection) of radiolabeled ODN. Of importance is the fact that the whole body retention of radioactivity increased with microsphere coinjection from 50.8%ID/g to 68.0%ID/g after 24-h of injection. This decreased kidney accumulation and increased whole body retention of [S-35]-labeled ODN resulted in a significant improvement of ODN targeting to the tumor site. In conclusion, the coinjection of microsphere appears to be an important carrier system in vehiculation of antisense oligonucleotide to the tumor tissue in vivo.

  • PDF